929
Views
10
CrossRef citations to date
0
Altmetric
Short Report

Two approaches for the stabilization of Bacillus anthracis recombinant protective antigen

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 560-565 | Received 30 Mar 2020, Accepted 16 May 2020, Published online: 02 Jul 2020

Figures & data

Figure 1. Spherical particles (SPs) generated by thermal remodeling of TMV. Scanning electron microscopy, without staining. Bar, 2 μm

Figure 1. Spherical particles (SPs) generated by thermal remodeling of TMV. Scanning electron microscopy, without staining. Bar, 2 μm

Figure 2. The stability of rPA83 within complexes with SPs. 1, 3, 5, 7, 9, 11, 13 – rPA83 within SPs-rPA83 complexes incubated under +25°C for 0, 2, 4, 6, 8, 10 and 12 days, respectively. 2, 4, 6, 8, 10, 12, 14 – Individual rPA83 incubated under +25°C for 0, 2, 4, 6, 8, 10 and 12 days, respectively. 15 – Protein molecular weight markers (molecular weights in kDa are indicated in the right).Red arrows indicate the considerable difference in stability between individual rPA83 and rPA83 within SPs-rPA83 complexes. Electrophoresis analysis, staining by Coomassie G-250

Figure 2. The stability of rPA83 within complexes with SPs. 1, 3, 5, 7, 9, 11, 13 – rPA83 within SPs-rPA83 complexes incubated under +25°C for 0, 2, 4, 6, 8, 10 and 12 days, respectively. 2, 4, 6, 8, 10, 12, 14 – Individual rPA83 incubated under +25°C for 0, 2, 4, 6, 8, 10 and 12 days, respectively. 15 – Protein molecular weight markers (molecular weights in kDa are indicated in the right).Red arrows indicate the considerable difference in stability between individual rPA83 and rPA83 within SPs-rPA83 complexes. Electrophoresis analysis, staining by Coomassie G-250

Figure 3. Bacillus anthracis recombinant antigens form complexes with SPs and retain antigenic specificity within complexes. (I) SPs-rPA83 complexes; (II) SPs-rPA3 + 4 complexes. (I) Phase contrast (a) and fluorescence microscopy (b) of SPs-rPA83FITC. (c) Immunoelectron microscopy of SPs-rPA83 complex. (II) Phase contrast (a) and fluorescence microscopy (b) of SPs-rPA3 + 4FITC. (c) Immunoelectron microscopy of SPs-rPA3 + 4 complex. rPA83FITC – rPA83 labeled with fluorescein isothiocyanate, rPA3 + 4FITC – rPA3 + 4 labeled with fluorescein isothiocyanate. For detection by immunogold microscopy was used primary antibodies to the rPA83 and secondary antibodies conjugated with colloidal gold (d = 12 nm) (“Jackson immunoresearch”, USA)

Figure 3. Bacillus anthracis recombinant antigens form complexes with SPs and retain antigenic specificity within complexes. (I) SPs-rPA83 complexes; (II) SPs-rPA3 + 4 complexes. (I) Phase contrast (a) and fluorescence microscopy (b) of SPs-rPA83FITC. (c) Immunoelectron microscopy of SPs-rPA83 complex. (II) Phase contrast (a) and fluorescence microscopy (b) of SPs-rPA3 + 4FITC. (c) Immunoelectron microscopy of SPs-rPA3 + 4 complex. rPA83FITC – rPA83 labeled with fluorescein isothiocyanate, rPA3 + 4FITC – rPA3 + 4 labeled with fluorescein isothiocyanate. For detection by immunogold microscopy was used primary antibodies to the rPA83 and secondary antibodies conjugated with colloidal gold (d = 12 nm) (“Jackson immunoresearch”, USA)

Figure 4. Schematic representation of rPA3 + 4 protein. The amino acid sequence coordinates are given according to UniProt Q08G54. Epitopes and asparagine (N) to glutamine (Q) substitutions are indicated. The scheme is not to scale

Figure 4. Schematic representation of rPA3 + 4 protein. The amino acid sequence coordinates are given according to UniProt Q08G54. Epitopes and asparagine (N) to glutamine (Q) substitutions are indicated. The scheme is not to scale
Supplemental material

Supplemental Material

Download MS Word (1.6 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.